SCHEMBL1905076

SCHEMBL1905076

CC(=O)OCCCCC=CCCCCOC(C)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
FAAH O00519 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 2/20 0.43
USP2 O75604 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43
RECQL P46063 1/20 0.43
CHRM5 P08912 2/20 0.43
CHRM1 P11229 2/20 0.43
CHRM3 P20309 2/20 0.43
PGR P06401 1/20 0.43
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
HTR1A P08908 1/20 0.43
CHRNB2 P17787 1/20 0.43
TBXA2R P21731 1/20 0.43
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
CHRNA7 P36544 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7910175 1.00 ALDH1A1 (0.56) ALDH1A1FAAHSMN1; SMN2LMNAUSP2
SCHEMBL1905075 1.00 ALDH1A1 (0.56) ALDH1A1FAAHSMN1; SMN2LMNAUSP2
SCHEMBL11491284 0.98 ALDH1A1 (0.54) ALDH1A1FAAHSMN1; SMN2LMNAUSP2
SCHEMBL21642625 0.98 ALDH1A1 (0.54) ALDH1A1FAAHSMN1; SMN2LMNAUSP2
SCHEMBL6432622 0.98 ALDH1A1 (0.54) ALDH1A1FAAHSMN1; SMN2LMNAUSP2
SCHEMBL4648599 0.98 ALDH1A1 (0.54) ALDH1A1FAAHSMN1; SMN2LMNAUSP2
SCHEMBL6432623 0.98 ALDH1A1 (0.54) ALDH1A1FAAHSMN1; SMN2LMNAUSP2
SCHEMBL21642626 0.98 ALDH1A1 (0.54) ALDH1A1FAAHSMN1; SMN2LMNAUSP2
SCHEMBL13921375 0.98 ALDH1A1 (0.54) ALDH1A1FAAHSMN1; SMN2LMNAUSP2
SCHEMBL11491287 0.98 ALDH1A1 (0.54) ALDH1A1FAAHSMN1; SMN2LMNAUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100528829-C Metathesis synthesis of pheromones or components thereof R L PEDERSON R H GRUBBS (US) 2009-08-19 CN claimed
EP-1230207-B1 METATHESIS SYNTHESES OF PHEROMONES OR THEIR COMPONENTS PEDERSON RICHARD L (US) 2005-06-22 EP claimed
US-6696597-B2 CROSS-METATHESIZING A TERMINAL OLEFIN AND INTERNAL OLEFIN IN PRESENCE OF CATALYST, TO FORM METATHESIS PRODUCT AND A SIDE PRODUCT; APPLYING CONDITIONS OF SUFFICIENTLY HIGH TEMPERATURE AND/OR LOW PRESSURE TO EVAPORTE SIDE PRODUCT TILLIECHEM, INC. 2004-02-24 US claimed
CN-1423629-A Metathesis synthesis of pheromones or components thereof PEDERSON R L (US) 2003-06-11 CN claimed
EP-1230207-A2 METATHESIS SYNTHESES OF PHEROMONES OR THEIR COMPONENTS Pederson, Richard L. (US) 2002-08-14 EP claimed
US-20020022741-A1 Metathesis syntheses of pheromones or their components MATERIA, INC. 2002-02-21 US claimed
WO-2001036368-A2 METATHESIS SYNTHESES OF PHEROMONES OR THEIR COMPONENTS PEDERSON RICHARD L (US) 2001-05-25 WO claimed
US-6215019-B1 SELF-METATHESIZING 1-HEXENE USING GRUBBS' CATALYST; CROSS-METATHESIZING PRODUCT WITH ALCOHOL OR ACETATE-PROTECTED HEXENE TILLIECHEM, INC. 2001-04-10 US claimed
EP-2321363-B1 TELECHELIC OLEFIN METATHESIS POLYMERS FROM RENEWABLE FEEDSTOCKS MATERIA INC (US) 2020-04-22 EP disclosed
EP-1395534-B1 IMPURITY INHIBITION IN OLEFIN METATHESIS REACTIONS MATERIA INC (US) 2017-08-30 EP disclosed
WO-2016103677-A1 METHOD FOR PRODUCING OMEGA-HYDROXY FATTY ACID ESTER AND PRECURSOR COMPOUND THEREOF KAO CORPORATION (JP) 2016-06-30 WO disclosed
CN-102177188-B Telechelic olefin metathesis polymers from renewable feedstocks MATERIA INC 2015-02-25 CN disclosed
US-8324334-B2 Telechelic olefin metathesis polymers from renewable feedstocks MATERIA, INC. (US) 2012-12-04 US disclosed
CN-102177188-A Telechelic olefin metathesis polymers from renewable feedstocks MATERIA INC 2011-09-07 CN disclosed
US-20030023123-A1 Impurity inhibition in olefin metathesis reactions MATERIA, INC. 2003-01-30 US disclosed
WO-2002094748-A1 IMPURITY INHIBITION IN OLEFIN METATHESIS REACTIONS PEDERSON RICHARD L (US) 2002-11-28 WO disclosed
EP-1230207-A2 METATHESIS SYNTHESES OF PHEROMONES OR THEIR COMPONENTS Pederson, Richard L. (US) 2002-08-14 EP disclosed
US-20020022741-A1 Metathesis syntheses of pheromones or their components MATERIA, INC. 2002-02-21 US disclosed
WO-2001036368-A2 METATHESIS SYNTHESES OF PHEROMONES OR THEIR COMPONENTS PEDERSON RICHARD L (US) 2001-05-25 WO disclosed
US-6215019-B1 SELF-METATHESIZING 1-HEXENE USING GRUBBS' CATALYST; CROSS-METATHESIZING PRODUCT WITH ALCOHOL OR ACETATE-PROTECTED HEXENE TILLIECHEM, INC. 2001-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030023123-A1 Impurity inhibition in olefin metathesis reactions CYP51A1, CYP1B1, SQLE ALDH1A1 513/4885FAAH 416/4885SMN1; SMN2 3822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.